Vivos Therapeutics Inc
(VVOS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 3,857 | 3,950 | 4,246 | 4,184 | 3,644 |
| Cost of Goods | 1,520 | 1,566 | 1,750 | 1,596 | 1,093 |
| Gross Profit | 2,337 | 2,384 | 2,496 | 2,588 | 2,551 |
| Operating Expenses | 7,862 | 8,971 | 8,653 | 10,148 | 9,283 |
| Operating Income | -5,005 | -6,021 | -5,407 | -6,964 | -6,639 |
| Other Income | 3,302 | -67 | -27 | -28 | 1,308 |
| Pre-tax Income | -1,703 | -6,088 | -5,434 | -6,992 | -5,331 |
| Net Income Continuous | -1,703 | -6,088 | -5,434 | -6,992 | -5,331 |
| Net Income | $-1,703 | $-6,088 | $-5,434 | $-6,992 | $-5,331 |
| EPS Basic Total Ops | -1.72 | -5.00 | -6.40 | -8.25 | -6.25 |
| EPS Basic Continuous Ops | -1.72 | -4.98 | -6.40 | -8.23 | -6.28 |
| EPS Diluted Total Ops | -1.72 | -5.00 | -6.40 | -8.25 | -6.25 |
| EPS Diluted Continuous Ops | -1.72 | -4.98 | -6.40 | -8.23 | -6.28 |
| EBITDA(a) | $-4,830 | $-5,852 | $-5,231 | $-6,681 | $-6,598 |